Oliveros, Rich Daniza L.
HRN: 25-38-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2024
MUPIROCIN 2%, 15G (TUBE)
07/09/2024
07/15/2024
TOPICAL
Peasize
BID
T/C Omphalitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes